← FDA Drug Approvals (Drugs@FDA)
WELLBUTRIN SR
NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1996-10-04
Drug application
- FDA Application #
NDA020358- Application type
- New Drug Application
- Brand name
- WELLBUTRIN SR
- Generic name
- BUPROPION HYDROCHLORIDE
- Active ingredients
- BUPROPION HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GLAXOSMITHKLINE
- Manufacturer
- GlaxoSmithKline LLC
- First approval
- 1996-10-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown